Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 5;12(7):788.
doi: 10.3390/healthcare12070788.

Potential Applications of Artificial Intelligence (AI) in Managing Polypharmacy in Saudi Arabia: A Narrative Review

Safaa M Alsanosi  1   2 , Sandosh Padmanabhan  2
Affiliations
Review

Potential Applications of Artificial Intelligence (AI) in Managing Polypharmacy in Saudi Arabia: A Narrative Review

Safaa M Alsanosi et al. Healthcare (Basel). .

Abstract

Prescribing medications is a fundamental practice in the management of illnesses that necessitates in-depth knowledge of clinical pharmacology. Polypharmacy, or the concurrent use of multiple medications by individuals with complex health conditions, poses significant challenges, including an increased risk of drug interactions and adverse reactions. The Saudi Vision 2030 prioritises enhancing healthcare quality and safety, including addressing polypharmacy. Artificial intelligence (AI) offers promising tools to optimise medication plans, predict adverse drug reactions and ensure drug safety. This review explores AI's potential to revolutionise polypharmacy management in Saudi Arabia, highlighting practical applications, challenges and the path forward for the integration of AI solutions into healthcare practices.

Keywords: Saudi Arabia; artificial intelligence; medication prescription; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Potential applications of AI in managing polypharmacy in Saudi Arabia.
Figure 2
Figure 2
SWOT analysis of using AI in managing polypharmacy in Saudi Arabia.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aljawadi M.H., Khoja A.T., Alaboud N.M., AlEnazi M.E., Al-Shammari S.A., Khoja T.A., AlMuqbil M.S., Alsheikh A.M., Alwhaibi M. Prevalence of Polypharmacy and Factors Associated with it among Saudi Older Adults—Results from the Saudi National Survey for Elderly Health (SNSEH) Saudi Pharm. J. 2022;30:230–236. doi: 10.1016/j.jsps.2022.01.003. - DOI - PMC - PubMed
    1. Alosaimi K., Alwafi H., Alhindi Y., Falemban A., Alshanberi A., Ayoub N., Alsanosi S. Medication Adherence among Patients with Chronic Diseases in Saudi Arabia. Int. J. Environ. Res. Public Health. 2022;19:10053. doi: 10.3390/ijerph191610053. - DOI - PMC - PubMed
    1. Alasiri A.A., Mohammed V. Healthcare Transformation in Saudi Arabia: An Overview Since the Launch of Vision 2030. Health Serv Insights. 2022;15:11786329221121214. doi: 10.1177/11786329221121214. - DOI - PMC - PubMed
    1. Maxwell S.R. Rational prescribing: The principles of drug selection. Clin. Med. 2016;16:459–464. doi: 10.7861/clinmedicine.16-5-459. - DOI - PMC - PubMed
    1. Johansson T., Abuzahra M.E., Keller S., Mann E., Faller B., Sommerauer C., Höck J., Löffler C., Köchling A., Schuler J., et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: A systematic review and meta-analysis. Br. J. Clin. Pharmacol. 2016;82:532–548. doi: 10.1111/bcp.12959. - DOI - PMC - PubMed

LinkOut - more resources